Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / ...
University of Manitoba independent research verifies that RuvidarTM is more effective than acyclovir in the inactivation of Herpes Simplex Viruses post infection. TORONTO, ON / ACCESS Newswire / Febru ...
Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...
Rhinoviruses are known as the most common cause of the common cold. However, the virus can cause a range of symptoms. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results